Oncimmune (ONC) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ONC Stock Alerts GBX 25.60 +0.70 (+2.81%) (As of 05/21/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 21 at 12:41 PM | lse.co.ukEARNINGS AND TRADING: Topps Tiles in strategic shift as swings to lossMay 17, 2024 | investing.comOncimmune Holdings PLC (ONCON)March 19, 2024 | wsj.comOncimmune Holdings PLCMarch 2, 2024 | finance.yahoo.comOncimmune Holdings Full Year 2023 Earnings: UK£0.085 loss per share (vs UK£0.13 loss in FY 2022)February 15, 2024 | reuters.comCancer test firm Freenome raises $254 mln in fresh fundingFebruary 14, 2024 | msn.comActivist investor Kelso gains board seats at The Works as it tries to enhance shareholder valueDecember 2, 2023 | proactiveinvestors.com.auOncimmune seeing commercial traction as it inks new deals with big pharma companiesSeptember 26, 2023 | yahoo.comThe Unique Use of Liquid BiopsyAugust 1, 2023 | marketwatch.comOncimmune's Acting CEO Ron Kirschner Steps Down, Takes COO Role; Gouldstone Starts as CEOJuly 14, 2023 | marketwatch.comOncimmune Shares Fall As Company Lowers FY 2022 Revenue ResultJuly 12, 2023 | lse.co.ukOncimmune names chief executive successor, while finance chief leavesJuly 12, 2023 | marketwatch.comOncimmune Holdings Appoints Martin Gouldstone CEO; CFO Matthew Hall to Step DownJune 23, 2023 | lse.co.ukOncimmune Holdings shakes up leadership and unveils new growth planJune 23, 2023 | marketwatch.comOncimmune CEO Adam Hill to Step Down; Sees Tough End to FY 2023May 31, 2023 | lse.co.ukOncimmune shares plummet as interim revenue falls by fifthMay 31, 2023 | marketwatch.comOncimmune Shares Fall on 1H Pretax LossMay 22, 2023 | lse.co.ukOncimmune sells two subsidiaries to Freenome for GBP13 millionMay 22, 2023 | markets.businessinsider.comFREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTDMay 22, 2023 | marketwatch.comOncimmune Eases Going-Concern Risk With Sale of Two Subsidiaries for GBP13 MlnApril 28, 2023 | marketwatch.comThe Comprehensive Guide to the Cancer Biopsy Market: Trends and Revenue Forecast with predicted CAGR of 4.2% from 2023-2030April 22, 2023 | marketwatch.comCancer Biopsy Market Outlook by 2031April 12, 2023 | finance.yahoo.comOncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual ConferenceFebruary 28, 2023 | proactiveinvestors.comOncimmune delivering top-line growthFebruary 27, 2023 | marketwatch.comOncimmune Shares Fall After Going Concern Warning, Pretax LossFebruary 20, 2023 | lse.co.ukCORRECT: Oncimmune works with Siemens Healthineers on cancer therapyJanuary 25, 2023 | theguardian.comRichard Sharp: BBC chair was shareholder in firm awarded £600k while he was a No 10 adviserJanuary 2, 2023 | finance.yahoo.comInvestors in Oncimmune Holdings (LON:ONC) have unfortunately lost 67% over the last yearDecember 7, 2022 | marketwatch.comOncimmune Holdings to Raise at Least GBP2.1 Mln; Mulls EarlyCDT IPOOctober 13, 2022 | finance.yahoo.comInstitutional investors own a significant stake of 48% in Oncimmune Holdings plc (LON:ONC)September 21, 2022 | lse.co.ukOncimmune shares plummet as company reports widened pretax lossSeptember 21, 2022 | marketwatch.comOncimmune FY 2022 Pretax Loss Widens on Higher Costs; Shares FallSeptember 2, 2022 | uk.finance.yahoo.comOncimmune Holdings Plc (ONC.L)July 31, 2022 | finance.yahoo.comEstimating The Fair Value Of Oncimmune Holdings plc (LON:ONC)June 16, 2022 | finance.yahoo.comFurther weakness as Oncimmune Holdings (LON:ONC) drops 12% this week, taking one-year losses to 56%June 2, 2022 | benzinga.comGlobal Cancer Biopsy Market to Reach USD 43,692 Million | Growing at CAGR of 10.7% | Insights and Tools and Forecast 2028April 21, 2022 | proactiveinvestors.com.auOncimmune receives 2022 Queen's Award for EnterpriseApril 8, 2022 | proactiveinvestors.com.auFTSE 100 ends the week higher as Wall Street also recoversApril 8, 2022 | proactiveinvestors.comFTSE follows US rally while Elon Musk faces potential SEC probe and UK starting salaries riseApril 8, 2022 | lse.co.ukOncimmune agrees two new commercial contractsMarch 7, 2022 | proactiveinvestors.com.auOncimmune lands follow-on Covid study contractMarch 7, 2022 | marketwatch.comOncimmune Holdings Wins Follow-On Contract for Covid-19 StudyFebruary 28, 2022 | marketwatch.comOncimmune 1H Pretax Loss Widened as Covid-19 Restrictions EaseFebruary 28, 2022 | morningstar.comOncimmune Signs Contract With Verily Life Sciences to Investigate Long-CovidFebruary 17, 2022 | marketwatch.comOncimmune Holdings's Lung Blood Test to Be Used in Spanish RegionFebruary 17, 2022 | proactiveinvestors.comOncimmune lung cancer diagnostic receives regulatory green light from second Spanish regional health authorityJanuary 4, 2022 | markets.businessinsider.comOncimmune Hldgs PLC : Results from COVID-19 autoantibody profiling panelDecember 31, 2021 | lse.co.ukOncimmune study suggests antibodies spike following Covid infectionDecember 26, 2021 | markets.businessinsider.comOncimmune Hldngs PLC : Grant of Options and PDMR DealingDecember 22, 2021 | markets.businessinsider.comOncimmune Hldngs PLC : ImmunoINSIGHTS commercial updateDecember 22, 2021 | markets.businessinsider.comOncimmune Hldngs PLC : PDMR Dealing Get Oncimmune News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… ONC Media Mentions By Week ONC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.000.44▲Average Medical News Sentiment ONC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼30▲ONC Articles Average Week Get Oncimmune News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OBI News OPTI News HEMO News DEST News OKYO News SNG News BVX News IMM News ROQ News C4XD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ONC) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncimmune Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.